| Pharmaceutical Information |
| Drug Name |
Frovatriptan |
| Drug ID |
BADD_D00976 |
| Description |
Frovatriptan is a triptan drug developed by Vernalis for the treatment of migraine headaches, in particular those associated with menstruation. Frovatriptan causes vasoconstriction of arteries and veins that supply blood to the head. |
| Indications and Usage |
For the acute treatment of migraine attacks with or without aura in adults. |
| Marketing Status |
Prescription |
| ATC Code |
N02CC07 |
| DrugBank ID |
DB00998
|
| KEGG ID |
D07997
|
| MeSH ID |
C108128
|
| PubChem ID |
77992
|
| TTD Drug ID |
D06FPQ
|
| NDC Product Code |
0378-3140 |
| Synonyms |
frovatriptan | 3-methylamino-6-carboxamido-1,2,3,4-tetrahydrocarbazole | Frova | VML-251 | VML251 | Frovelan | SB 209509 | Allegro | frovatriptan succinate | (+)-(R)-5,6,7,8-tetrahydro-6-(methylamino)carbazole-3-carboxamide succinate (1:1), monohydrate |
|
| Chemical Information |
| Molecular Formula |
C14H17N3O |
| CAS Registry Number |
158747-02-5 |
| SMILES |
CNC1CCC2=C(C1)C3=C(N2)C=CC(=C3)C(=O)N |
| Chemical Structure |
|
|
| ADR Related Proteins Induced by Drug |
| ADR Term |
Protein Name |
UniProt AC |
TTD Target ID |
PMID |
| Not Available | Not Available | Not Available | Not Available | Not Available |
|
| ADRs Induced by Drug |
|
|
